Board of Directors approved the convening of the
2022 Annual Shareholders' Meeting
Date of events
2022/03/23
To which item it meets
paragraph 17
Statement
1.Date of the board of directors' resolution:2022/03/23
2.Shareholders meeting date:2022/06/29
3.Shareholders meeting location:No.12, Fuxing 4th Rd., Qianzhen
Dist.,Kaohsiung City,Taiwan(R.O.C)
4.Shareholders meeting will be held by means of (physical shareholders
meeting/ visual communication assisted shareholders meeting /
visual communication shareholders meeting):physical shareholders meeting
5.Cause for convening the meeting (1)Reported matters:
(1)To report the business of 2021.
(2)Audit Committee's review report of 2021.
(3)To report 2021 employees' profit sharing and directors'
compensation.
6.Cause for convening the meeting (2)Acknowledged matters:
(1)To accept 2021 Business Report and Financial Statements.
(2)To accept 2021 earnings distribution.
7.Cause for convening the meeting (3)Matters for Discussion:
(1)To revise the Articles of Incorporation.
(2)To revise the Procedures for Acquisition or Disposal of Assets.
(3)To revise the Regulations Governing the Election of Directors.
8.Cause for convening the meeting (4)Election matters:None.
9.Cause for convening the meeting (5)Other Proposals:None.
10.Cause for convening the meeting (6)Extemporary Motions:None.
11.Book closure starting date:2022/05/01
12.Book closure ending date:2022/06/29
13.Any other matters that need to be specified:In accordance with the
Article 172-1 of the Company Act, the provisions on the right to accept
shareholder proposals are formulated.
(1)Proposal acceptance period: Shareholders holding 1% over or more would
like to propose at the shareholders' meeting, the company will receive
proposals from April 22 to May 3,2022.
(2)Address: No.1,S.1st Rd.,Qianzhen Dist.,Kaohsiung City,Taiwan(R.O.C).
Attachments
Original Link
Original Document
Permalink
Disclaimer
SciVision Biotech Inc. published this content on 23 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 March 2022 09:03:02 UTC.
SciVision Biotech Inc is principally engaged in the manufacturing and distribution of hyaluronic acid medical supplies. The Company primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The Company is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The Company operates its business in the Americas, Europe, Asia, Middle East and Africa.
SCIVISION BIOTECH INC. 
